Herantis Pharma Oyj
Herantis Pharma Oyj (HRPMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HRPMF · as of Jun 9, 2026
Key Statistics
Explore Herantis Pharma Oyj Data
hrpmf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hrpmf competitorsHRPMF
BSTG
DMTTF
EEOIF
GDNSF
KDEVFStock Performance
Full HistoryAbout Herantis Pharma Oyj
Herantis Pharma Oyj a biotechnology enterprise, specializes in creating disease-modifying therapies for Parkinson's disease (PD) that harness Cerebral Dopamine Neurotrophic Factor (CDNF). Central to …
what is herantis pharma oyj · hrpmf stock overview · herantis pharma oyj company profile · who is herantis pharma oyj ceo · hrpmf OTC · herantis pharma oyj headquarters · herantis pharma oyj business segments
About Stock Overview & Key Data
Herantis Pharma Oyj (HRPMF) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 30, 2018. As of the latest trading session, HRPMF stock price is $3.51, with a market capitalization of $59.5M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2024, Herantis Pharma Oyj reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Herantis Pharma Oyj (HRPMF) stock price is $3.51. The stock is traded on OTC under the ticker symbol HRPMF. The 52-week range is $3.51 – $3.51.